Haoxi Health Technology (HAO) Cash & Equivalents (2023 - 2025)

Haoxi Health Technology's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $6.8 million for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 25.23% year-over-year to $6.8 million; the TTM figure through Dec 2025 stood at $6.8 million (down 25.23% YoY), while the FY2025 annual figure was $8.6 million, up 29.49% from the prior year.
• Cash & Equivalents was $6.8 million for Q4 2025 at Haoxi Health Technology, down from $8.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $9.1 million in Q4 2024 to a low of $1.2 million in Q2 2023.
• Historically, Cash & Equivalents has averaged $5.6 million across 3 years, with a median of $6.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents jumped 656.02% in 2024, then decreased 25.23% in 2025.
• A 3-year view of Cash & Equivalents shows it stood at $1.2 million in 2023, then surged by 656.02% to $9.1 million in 2024, then dropped by 25.23% to $6.8 million in 2025.
• The last three Cash & Equivalents figures came in at $6.8 million (Q4 2025), $8.6 million (Q2 2025), and $9.1 million (Q4 2024), per Business Quant data.